| CELL-FREEFE TALDNAINPREG NAN C Y
Cell-free fetal DNA (cffDNA) is a group of small DNA fragments <313 bp length that are derived from apoptotic and necrotic placental cells and released into maternal circulation. 1, 2 During normal gestation, cffDNA undergoes a progressive rise, which peaks at term and then rapidly drops to undetectable levels post-partum. [2] [3] [4] [5] In support of this, increasing apoptosis of trophoblast cells has been observed at the end of pregnancy. [6] [7] [8] [9] Elevated circulating levels of cffDNA have been reported in adverse pregnancy complications. [10] [11] [12] [13] [14] The questions arise whether cffDNA can be used as a putative biomarker for pregnancy complications and whether cffDNA in normal pregnancy is different from gestation with adverse pregnancy outcomes. Recently, detection of cffDNA in maternal blood has been developed as a non-invasive prenatal diagnostic test to detect chromosomal abnormalities in the fetus. 15 To this end, epidemiological studies with a focus on the SRY/DYS/RhD gene sequences in maternal plasma/serum have shown that cffDNA is significantly elevated in women with adverse pregnancy outcomes including preterm birth, [16] [17] [18] [19] [20] [21] fetal growth restriction, 22 gestational diabetes, 23 and preeclampsia. 11, [24] [25] [26] Human cffDNA contains unmethylated CpG motifs similar to bacterial and viral DNA. Thus, cffDNA may interact with Toll-like receptor 9 (TLR9), a pattern recognition receptor involved in innate immunity, leading to the activation of NF-kB and increased production of pro-inflammatory cytokines and chemokines. 5 On the other hand, cffDNA may activate stimulator of interferon genes (STING), 15 a protein that is expressed in hematopoietic
There exists a strong correlation between unscheduled inflammation at the maternalfetal interface and the continuum of pregnancy complications. In normal pregnancy, immunological tolerance is established to protect the semi-allogeneic fetus. There has been extensive research on how the immunity, endovascular trophoblast migration, and hormonal nexus are orchestrated during pregnancy at the maternal-fetal interface to program a normal pregnancy outcome. It is not clear what contributes to the plasticity of uterine immune tolerance, fetal survial, and long-term post-partum health of the mother and the offspring. Old and new concepts have reemerged and emerged that include cell-free fetal DNA (cffDNA), telomere shortening, microchimerism involving bidirectional migration of maternal and fetal cells, and pregnancy as a stress factor. The question is how these pathways converge in a gestational agedependent manner to contribute to the health of the mother and the offspring later in life and respond to an array of inflammatory challenges. In this Review, we provide pertinent discussion on maternal-fetal cross talk through cffDNA, telomere shortening, and microchimerism in the context of inflammatory and anti-inflammatory settings, particularly how these pathways lead to normal and adverse pregnancy outcomes.
K E Y W O R D S
adverse pregnancy outcomes, cell-free fetal DNA, immune tolerance, microchimerism, This suggests that cffDNA may not bet an exclusive factor that contributes to the pathogenesis of pregnancy complications. Thus, in vivo investigation of cffDNA-associated pathological effects may be warranted in the context of other immune dysregulations. In addition, studies using cffDNA that is extracted from placental tissue or trophoblast cells from complicated pregnancies are also needed to address the role of cffDNA in adverse pregnancy outcomes.
| TELOMEREMIMI CRYINPREG NAN C Y
Telomeres are the domains of repetitive DNA sequences (eg, TTAGGG in mammals) at the distal ends of linear chromosomes, which protect the end of the chromosome from breaks or from endto-end fusion, and thereby maintain genomic structural integrity and cell survival. 5 Generally, telomeres are progressively shortened with each cell division, and thus, telomere length is considered to be a determinant of biological clock for natural aging. 4, 5, 33 Normally, telomeres are synthesized by the reverse transcriptase enzyme known as telomerase. Regulation of telomere length can be affected by environmental factors such as oxidative stress. Oxidative stress has been shown to cause telomere shortening by breaking doublestrand DNA structure and inhibiting repair of telomere breaks via reducing telomerase activity and expression. [34] [35] [36] Telomere shortening in turn makes telomeres more susceptible to oxidative stress and further damage. 37 A critical telomere shortening can cause cells to undergo an irreversible proliferative arrest named cellular senescence [38] [39] [40] and apoptosis through p53-dependent and p53-independent events. [41] [42] [43] Additionally, telomere loss and the resulting senescence have also been shown to trigger sustained activation of transcription factor NF-κB and overexpression of inflammatory cytokines such as TNF-α, IL-6, and IFN-γ in circulating macrophages, leading to chronic inflammation. 4, 44 A gradual progression of natural physiological senescence has been found in maternal decidual cells, trophoblasts, and fetoplacental membranes of normal pregnancy, which may contribute to the mechanisms of parturition at term. Consistent with these findings, placental and fetal membrane cells have been found to have weak or no telomerase activity, especially during late gestation.
5,45
Recent data demonstrated that this natural progressive loss of telo- Adverse uterine environment can lead to altered fetal programming that may contribute to increased health risks in the offspring. In this regard, a prior study indicated an association between maternal stress during pregnancy and telomere shortening in the offspring. 59 Menon et al reported shorter telomere length observed in children born to mothers who smoke during pregnancy. 60 Moreover, maternal nutritional and sleeping disorders during pregnancy are also linked to fetal telomere shortening. 61 Recently, Phillippe et al proposed an interesting "cffDNA/telomere" hypothesis to provide a mechanistic explanation for normal parturition and the spontaneous preterm birth. 5 This hypothesis described that telomere shortening induces apoptosis in placental tissues and subsequently leads to release of cffDNA. As a result, TLR9-promoted inflammatory cascades are activated and reinforced by reduced IL-10 expression in the placenta during late gestation.
The activated innate immune response enhances the expression and function of uterine activation proteins, matrix metalloproteinases, and uterotonins, leading to cervical ripening, rupture of the membranes, and the onset of phasic myometrial contractions. 5 In support of this hypothesis, there have been many studies showing these signaling events involved in regulating spontaneous parturition at term. 5 However, dysregulation of these signaling events may result in spontaneous preterm parturition. In this regard, elevated cffDNA levels 16, 17, 19 and suppressed IL-10 production 28, 40, 63, 64 have been linked to pregnancies complicated with preterm delivery in pre-clinical models. Additionally, a prior study showed significant lower levels of IL-10 in African American women compared to white women. 65 This observation is correlated with the fact that African
American women have higher levels of telomere shortening, shorter gestation, and higher rates of preterm birth.
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| DOE SINFL AMMATI ON ,INFEC TI ON , ORS TRE SSD IS RUP TMI CRO CHIMERIS M DURINGPREG NAN C Y ?
Microchimerism in pregnancy is defined as a vertical transfer of maternal cells to the fetus at detectable levels. Reciprocally, fetal cells can also be found in mothers, making the microchimerism exchange between the mother and the fetus a physiologically relevant process. 67, 68 This bidirectional migration of cells occurs at a very low level, albeit 1 in 10 3 fetal cells in maternal PBMCs at the beginning of second trimester of human pregnancy, 69 and is highly conserved across placental pregnancies in mammals. The process may start very early in gestation as observed in both humans and mice. [70] [71] [72] Accumulation of microchimeric cells reaches peak during the late stages of pregnancy, and these cells can persist for decades after delivery. 67 It has been suggested that maternal microchimeric cells are involved in the maturation of fetal immune system. Tregs from fetal CD4 + T cells. 72 There have been numerous reports suggesting that circulating Tregs begin to increase in numbers very early in pregnancy and reach peak mid-gestation. 73 This parallels the increase in uterine Tregs. Their absence or functional dysregulation has been associated with failed implantation or pregnancy loss. 74, 75 These observations suggest that bidirectional seeding of maternal or fetal cells helps during pregnancy and beyond. 
| MATERNALTOLER AN CETO PATERNAL-FE TALANTIG ENS
As described above, there are many physiological events such as cffDNA, gestational age-dependent shortening of telomere, and maternal and fetal microchimeric cells generated from the mother and the semi-allogeneic fetus during normal pregnancy. How does maternal immune system orchestrate the interplay involving this cascade of events to maintain a successful pregnancy? A successful pregnancy is a unique and well-choreographed balance between pro-inflammatory and anti-inflammatory responses, leading to maternal immune tolerance. [77] [78] [79] [80] Indeed, the maternal immune tolerance plays a pivotal role in the regulation of placentation, trophoblast invasion, and angiogenesis, and thus is essential for placental development and normal fetal growth. 77 Defective fetal allorecognition and impaired immune response have been involved in poor placentation, release of pro-inflammatory cytokines, and hormonal imbalance at the maternal-fetal interface, leading to adverse reproductive outcomes.
77,79
The mechanisms underlying maternal immune tolerance to Epidemiological studies have revealed that prior and prolonged exposure to paternal seminal fluid decreases the likelihood of preeclampsia, and inadequate maternal exposure to paternal antigens prior to pregnancy enhances risk of preeclampsia. 105, 106 This implies that exposure to paternal alloantigens may facilitate maternal immune tolerance to paternal HLA. 106 Mechanistically, seminal fluid exposure has been shown to promote maternal immune tolerance to paternal antigens through expansion of the Tregs pool. 107 Moreover, pregnancy selectively induces the expansion of fetal-specific Tregs, and after delivery, these Tregs may still persist, and sustain tolerance to pre-existing paternal-fetal antigens carried in microchimeric cells. 108 These findings may explain why a first pregnancy confers tolerance to a second pregnancy and why incidence rates of preeclampsia and other adverse pregnancy outcomes associated with inadequate fetal tolerance are decreased in second pregnancy as compared to first pregnancy. 108 Expanded immune tolerance primed by pregnancy persists not only in mothers but also in the offspring due to retaining of reciprocally transferred maternal and fetal microchimeric cells, which has been reviewed in detail by Kinder et al. 72 Despite extensive investigation, many issues regarding the mechanisms for maternal immune tolerance still remain to be ad- 
| CON CLUS ION
Pregnancy is a complex but highly choreographed process involving an active cross talk between maternal and fetal tissues throughout of attention as a result of advanced maternal age of pregnancy, increasing incidence of pregnancy complications such as preterm parturition, preeclampsia, and gestational diabetes, and challenges from sterile and infection-associated inflammation. Understanding and answering questions related to cffDNA, telomere shortening, and microchimerism will not only add to our knowledge regarding the biology of pregnancy, but mechanisms underlying these multiple pregnancy complications will allow the development and availability of much improved therapeutic options and diagnostic tests. The themes discussed in this review are currently the focus of extensive research and may present a major paradigm shift in our thinking related to normal pregnancy and adverse pregnancy outcomes.
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